Spero Therapeutics, Inc. (SPRO)
2.74
-0.06
(-2.14%)
USD |
NASDAQ |
Apr 24, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Spero Therapeutics EPS Diluted (Quarterly) : 0.5309 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0758 |
| SELLAS Life Sciences Group, Inc. | -0.05 |
| Nephros, Inc. | 0.0055 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.52M |
| Revenue (Quarterly) | 39.66M |
| Total Expenses (Quarterly) | 8.138M |
| Enterprise Value | 121.25M |
| Profit Margin (Quarterly) | 79.48% |
| Earnings Yield | 4.34% |
| Normalized Earnings Yield | 4.730 |